Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction: Results of a randomized, placebo-controlled, dose- ranging trial
Academic Article
Overview
MeSH Major
Fibrinolytic Agents
Myocardial Infarction
Peptides
Platelet Aggregation Inhibitors
Tissue Plasminogen Activator
abstract
The incidence and speed of reperfusion can be enhanced when a potent inhibitor of the glycoprotein IIb/IIIa integrin receptor, such as Integrilin, is combined with accelerated alteplase, aspirin, and intravenous heparin.
